Showing results (281-290 of 397) with videos related to

Sort By:
Pageof 40
Psychopharmacology|January 7, 1999
Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effectsL L von Moltke, D J Greenblatt, J M Grassi, et al.
Frontiers in Pediatrics|September 23, 2022
Microbiological screening tests for SARS-CoV-2 in the first hour since the hospital admission: A reliable tool for enhancing the safety of pediatric careGiuseppe Vetrugno, Simone Grassi, Francesco Clemente, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 10, 2017
Medication therapy disease management: Geisinger's approach to population health managementLaney K Jones, Gerard Greskovic, Dante M Grassi, et al.
Neurology|September 2, 2009
Common genetic markers and prediction of recurrent events after ischemic stroke in young adultsA Pezzini, M Grassi, E Del Zotto, et al.
Healthcare (Basel, Switzerland)|May 27, 2023
Analysis of Medico-Legal Complaint Data: A Retrospective Study of Three Large Italian University HospitalsNicola Di Fazio, Matteo Scopetti, Giuseppe Delogu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 7, 2019
Natural Killer Response and Lipo-Metabolic Profile in Adults with Low HDL-Cholesterol and Mild Hypercholesterolemia: Beneficial Effects of Artichoke Leaf Extract SupplementationM Rondanelli, A M Castellazzi, A Riva, et al.
The European Respiratory Journal|September 1, 2009
Last 3 months of life in home-ventilated patients: the family perceptionM Vitacca, M Grassi, L Barbano, et al.
Journal of Patient Safety|April 19, 2023
Comparative Impact Analysis of Low-Deductible Insurance Versus In-house Hospital Assumption of Risk and Management on Medical Malpractice ClaimsGiuseppe Vetrugno, Simone Grassi, Federica Foti, et al.
Oncology|October 2, 2004
Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-upS Barni, E Piazza, L Frontini, et al.
Breast (Edinburgh, Scotland)|March 10, 2023
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trialsLaura Pala, Tommaso De Pas, Eleonora Pagan, et al.
Pageof 40